Summary of product characteristics imvanex
WebMODULE 1.3 SUMMARY OF PRODUCT CHARACTERISTICS Article 8(3)(j) of Directive 2001/83/EC and Article 6(1) of Regulation (EC) 726/2004 require that, in order to obtain a … Web7 rows · 17 Sep 2024 · Overview. Imvanex is a vaccine used to protect against smallpox in adults. It contains an ...
Summary of product characteristics imvanex
Did you know?
WebThis medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. 1. NAME OF THE MEDICINAL PRODUCT WebIMVANEX should not be administered by intravascular injection. The protective efficacy of IMVANEX against smallpox has not been studied. See section 5.1. A protective immune …
WebIMVANEX may trigger local rashes or more widespread eruptions. Events of rash after vaccination (related cases observed in 0.64% of subjects) with IMVANEX tend to occur … WebSPC - Summary of product characteristics: imvanex-epar-product-information_cs.pdf: NR - Registration decision: PIL - Package leaflet: imvanex-epar-product-information_cs.pdf: …
Webany other veterinary medicinal product except the products mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to … WebMonkeypox (MPX) has been regarded as a neglected tropic disease of Western and Central Africa since the early 70s. However, during May 2024, an unprecedent outbreak of MPX …
WebA Summary of Product Characteristic (or SmPC) is a monograph for medicines written and updated by pharmaceutical companies based on their product research and knowledge. It …
WebIMVANEX should not be administered by intravascular injection. The protective efficacy of IMVANEX against smallpox has not been studied. See section 5.1. A protective immune … dr binder boston medical centerWebChapter 29 - 1 Smallpox and monkeypox C 29 S 26 September 2024 S NOTIFIABLE T S Smallpox is a highly transmissible disease which was one of the most severe infectious diseases affecting humans. dr binder casper wyomingdr binder chiropracticWebIMVANEX may trigger local rashes or more widespread eruptions. Events of rash after vaccination (related cases observed in 0.4% of subjects) with IMVANEX tend to occur within the first days after vaccination, are mild to moderate in intensity and usually resolve … dr binder casper wyWebIMVANEX and sodium This medicinal product contains less than 1mmol sodium (23 mg) per dose and is therefore essentially ‘sodium-free’. How IMVANEX is given The vaccine will be … enable precision boost overdriveWeb17 Mar 2024 · Investors. We are committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and … dr binder chiropractorWebImvanex is a vaccine used to protect against smallpox in adults. It contains a live modified form of the vaccinia virus called 'vaccinia Ankara', which is related to the smallpox virus. … dr. binderow atlanta ga